US Edition
Published • loading... • Updated
Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight
Summary by ts2.tech
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlight
Organon shares jumped 25% Friday after The Economic Times reported Sun Pharma made a binding $13 billion all-cash takeover offer, backed by $12 billion in bank financing. Sun Pharma shares fell over 3% in Mumbai. Neither company has confirmed a deal. Organon, based in Jersey City, posted $6.2 billion in 2025 revenue and holds $8.64 billion in debt. The post Organon Stock Jumps as Sun Pharma’s Reported $13 Billion Bid Puts OGN in Takeover Spotlig…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
